Related Experiment Videos
The effect of TN-16 on the alkylation of tubulin
Abstract:
The synthetic anti-tumor drug 3-(1-anilinoethylidene)-5-benzylpyrrolidine-2,4-dione (TN-16) is known to block microtubule assembly and colchicine binding to tubulin, although its structure does not resemble those of either colchicine, podophyllotoxin, or nocodazole (Arai, FEBS Lett. 155:273-276 (1983]. We have found that TN-16 affects the intra-chain cross-linking of beta-tubulin by N,N'-ethylene-bis(iodoacetamide) in a manner identical to that of colchicine, podophyllotoxin, and nocodazole, but different from that of vinblastine or maytansine. TN-16 also inhibits alkylation of tubulin by iodo[14C]acetamide, as do colchicine and its congeners. TN-16 appears to bind to tubulin at the colchicine binding site and one of its phenyl groups is likely to bind at the site on tubulin where colchicine's A ring binds.
Insights
The anti-tumor drug TN-16 disrupts microtubule assembly by binding to the same site as colchicine on tubulin. This mechanism is distinct from other anti-cancer agents like vinblastine.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Microtubules are essential components of the cytoskeleton, playing critical roles in cell division and intracellular transport.
- Disruption of microtubule dynamics is a key mechanism for many anti-cancer drugs.
- Colchicine is a well-known microtubule-disrupting agent that binds to tubulin.
Purpose of the Study:
- To investigate the mechanism of action of the synthetic anti-tumor drug 3-(1-anilinoethylidene)-5-benzylpyrrolidine-2,4-dione (TN-16).
- To determine if TN-16 interacts with tubulin at the colchicine binding site.
- To compare the effects of TN-16 on tubulin with those of other known anti-mitotic agents.
Main Methods:
- Assessing the effect of TN-16 on the intra-chain cross-linking of beta-tubulin by N,N'-ethylene-bis(iodoacetamide).
- Evaluating the inhibition of tubulin alkylation by iodo[14C]acetamide in the presence of TN-16.
- Comparing TN-16's effects with those of colchicine, podophyllotoxin, nocodazole, vinblastine, and maytansine.
Main Results:
- TN-16 affects beta-tubulin cross-linking similarly to colchicine, podophyllotoxin, and nocodazole, but differently from vinblastine and maytansine.
- TN-16 inhibits the alkylation of tubulin by iodo[14C]acetamide, a characteristic shared with colchicine.
- Evidence suggests TN-16 binds to the colchicine binding site on tubulin, with a phenyl group potentially interacting where colchicine's A ring binds.
Conclusions:
- TN-16 functions as a microtubule assembly inhibitor by binding to the colchicine binding site on tubulin.
- The binding interaction of TN-16 with tubulin shares similarities with colchicine and its analogues.
- TN-16 represents a novel structural class of anti-tumor agents targeting tubulin at the colchicine site.